SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Verastem, Inc. is a biopharmaceutical company, which engages in the development and commercialization of drugs for the treatment of cancer. The company was founded by Richard H. Aldrich, Michelle Dipp, Piyush Gupta, Satish Jindal, Eric S. Lander, Robert F. Weinberg, and Christoph H. Westphal on August 4, 2010 and is headquartered in Needham, MA.

Verastem Inc

Verastems VS-7375 clinical update is the main focus, with the company reporting encouraging KRAS G12D activity, including a 50% confirmed response rate in second-line pancreatic cancer, alongside favorable tolerability. Traders are weighing the results potential against the stocks decline and a newly priced share offering; some view the offering price as investor confidence, while others are concerned about dilution.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Discussion centers on new immune-biomarker findings for Candels CAN-2409 prostate cancer program and the planned BLA submission, with bullish traders viewing the data as support for the treatments potential and regulatory case. Others remain concerned about the stocks decline despite positive updates, BLA timing, and possible dilution, with some also criticizing the CEOs share sale.

Liquidia Corp. operates as a holding company which engages through its subsidiary in developing and commercializing biopharmaceutical products and novel products development used in PRINT technology to transform the lives of patients. The company was founded in June 2004 and is headquartered in Morrisville, NC.

Liquidia Corp

Liquidias settlement with United Therapeutics resolves their litigation and keeps YUTREPIA available for PAH, while the PH-ILD indication is being removed. Traders see relief from the risk of losing access to the market, but debate whether the costly settlement and lost indication outweigh that benefit.

Paramount Skydance Corp. is a next-generation global media and entertainment company that engages in providing content creation and distribution services. It operates through the following business segments: Studios, Direct-to-Consumer, and TV Media. Its portfolio unites brands including Paramount Pictures, Paramount Television, CBS, CBS News, Nickelodeon, MTV, BET, Comedy Central, Showtime, Paramount Plus, Pluto TV, and Skydance’s Animation, Film, Television, Interactive/Games, and Sports divisions. The company is headquartered in New York, NY.

Skydance Corp. - Ordinary Shares - Class B

Skydances distribution of long-dated warrants and the shift to ex-warrant trading dominate discussion, with traders debating whether the share-price adjustment reflects the warrants separated value or additional selling pressure. Concerns about potential dilution and the debt burden from the Warner Bros. Discovery deal add to the bearish reaction, while some holders argue the warrants offset the stocks decline.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is under pressure amid a broader AI-infrastructure selloff, as OpenAI revenue disclosures renewed doubts about whether AI demand can support the sectors heavy buildout. Bears are also focused on CoreWeaves debt, capital spending and financing costs, while bulls call the demand concerns overblown and point to its backlog and capacity expansion.

ASML Holding NV engages in the development, production, marketing, sales, upgrading and servicing of advanced semiconductor equipment systems. It includes lithography, metrology and inspection systems. The company was founded on April 1, 1984 and is headquartered in Veldhoven, the Netherlands.

ASML Holding NV - New York Shares

ASML Holding NV

ASMLs quarterly results and raised full-year sales outlook are driving discussion, with management citing strong AI-related equipment demand that may outstrip planned supply in coming years. Traders are divided over the share-price decline: bulls call it a sell-the-news reaction to solid results and demand, while skeptics point to a slight sales miss and the lack of a 2027 outlook.

United Therapeutics Corp. is a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening conditions. Its products include Adcirca, Orenitram, Remodulin, TYVASO, and Unituxin. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.

United Therapeutics Corp

United Therapeutics global settlement with Liquidia resolves six lawsuits and keeps YUTREPIA available for PAH while removing its PH-ILD indication, a development traders view as protecting UTHRs Tyvaso franchise. Some posts note that Liquidias continued PAH sales limit the competitive impact, while others question why UTHR shares have reacted modestly to the deal.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

CEO Ryan Cohens latest large open-market share purchase, continuing a run of insider buying, is driving attention. Many traders view it as a bullish signal and link it to warrant-related or short-squeeze speculation, while others argue insider purchases alone are not a substitute for meaningful company news.

AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology. The company was founded in 1913 and is headquartered in Cambridge, the United Kingdom.

Astrazeneca plc

AstraZeneca PLC

AstraZenecas $2 billion strategic investment in Summit Therapeutics, paired with plans to study Summits cancer drug ivonescimab in combination with AstraZeneca therapies, is drawing attention. Traders largely describe the deal as a vote of confidence and an expansion of AZNs oncology strategy, while some question Summits valuation and stress that the investment is not a buyout.

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class A

Alphabet Inc Class A

Googles Gemini 4 Argon rollout is driving AI-focused discussion, with traders debating its competitiveness against Meta and other frontier models. Reactions are mixed: some expect the launch and cloud growth to support the shares, while others point to a muted, choppy price response and fading hype.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Big-bank earnings are drawing attention to XLF, with JPMorgans earnings missespecially weaker trading revenueprompting debate over whether the shortfall is an isolated, volatile result or a warning for financials. Traders are also weighing upcoming bank reports against broader pressure from elevated rates and concerns about loan demand and dealmaking.

Wells Fargo CFO Says Growth Opportunities Remain ‘Just As Big’ After Mixed Q3 – Sees Higher Rates Supporting Lending Margins

Equity

Wells Fargo’s Q3 results painted a mixed picture, with stronger loan growth and improving performance across its businesses offset by a revenue miss and higher credit-loss provisions.

Goldman CEO David Solomon Says Firm Is ‘Very Well Positioned’ Despite Global Uncertainties - GS Stock Gains On Q3 Earnings Beat

CEO David Solomon highlighted Goldman Sachs’ client relationships and long-term growth plans as the firm reported higher year-over-year revenue and earnings in the third quarter.


S&P 500’s Narrow Rally Faces Fresh Tests From CPI, Bank Earnings: 3 Charts To Watch This Week

The S&P 500 has climbed roughly 80% since the start of 2024, but the equal-weight index has lagged as gains concentrate in the largest companies.


SOFI, AFRM, COF, KLAR, SEZL: Which Consumer Finance Stocks Does Wall Street Like Best Ahead Of Q3 Earnings? 

TD Cowen analyst Moshe Orenbuch named Capital One and Affirm among its top consumer finance picks.

XLF, XYZY: Big ETF Outflows

Looking at units outstanding versus one week prior within the universe of ETFs covered at ETF Channel, the biggest outflow was seen in the State Street Financial Select Sector SPDR ETF, where 17,404,573 units were destroyed, or a 1.8% decrease week over week. Among the largest...

Should You Invest in the State Street Financial Select Sector SPDR ETF (XLF)?

COIN Stock Hits 4-Month High Amid Crypto Rally As Coinbase Makes IPO Allocations Available To Retail Traders 

Coinbase will kick off its new service with IPO access to Oura’s offering later this week.


Midterm Takes Center Stage: What Does It Mean for Markets & ETFs?

Trump's midterm push, election uncertainty and AI's political scrutiny could shape markets. Explore ETFs positioned for potential sector and post-election gains.

AMC Vs. Robinhood: Vlad Tenev Lays Out 3 Factors Behind Stock Tokenization Consent

In an interview with CNBC, Robinhood CEO Vlad Tenev pushed back against AMC CEO Adam Aron’s criticism of Robinhood’s tokenized AMC shares.

Aon CEO Believes $17B USI Deal May Be 'The Greatest’ Value-Creation Opportunity Of His Career

In an interview with CNBC, Aon CEO Greg Case said the USI deal, combined with Aon’s 2024 NFP acquisition, is expected to create a “premier U.S. middle market platform.”


Select Sector SPDR Trust (The) - State Street Financial Select Sector SPDR ETF

Bullish Sentiment

Yes, buying

No, staying away

Just holding what I have

Watching from the sidelines

SoFi Technologies ($SOFI) stock is falling despite reporting record Q2 2026 revenue of $1.22 billion, up 42% year-over-year, and raising its full-year guidance on strong lending and member growth. Are you buying the dip? Vote and explain your reasoning in the comments.

SoFi ($SOFI) stock is down despite record Q2 revenue and raised full-year guidance. Are you buying the dip?

Stocktwits

SoFi Technologies Inc

) stock is down despite record Q2 revenue and raised full-year guidance. Are you buying the dip?

Current Price	$54.82
Prev Close	$55.05
Open	$55.42
Dividend Yield	N/A
50-Day Moving Average	$56.44
Beta	N/A
Avg. Volume	37.38M
PE Ratio	N/A

52-Week High	$58.60
52-Week Low	$47.67
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A

Feed

News

Sentiment

Fundamentals

Info

XLF Fundamentals